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Abstract
Background: Health benefits of the Mediterranean Diet (MD) have been shown in different at-risk populations. A
German translation of the Mediterranean Diet Adherence Screener (MEDAS) from the PREvención con DIeta MEDiterránea
(PREDIMED) consortium was used in the LIBRE study, investigating effects of lifestyle-intervention on women with BRCA1/
2 mutations. The purpose of the present study is to validate the MEDAS German version.
Methods: LIBRE is a multicentre (three university hospitals during this pilot phase), unblinded, randomized, controlled
clinical trial. Women with a BRCA1/2 mutation of age 18 or over who provided written consent were eligible
for the trial. As part of the assessment, all were given a full-length Food Frequency Questionnaire (FFQ) and
MEDAS at baseline and after 3 months. Data derived from FFQ was compared to MEDAS in order to evaluate
agreement or concordance between the two questionnaires. Additionally, the association of dietary intake biomarkers in
the blood (β-carotene, omega-3, omega-6 and omega-9 fatty acids and high-sensitivity C-reactive protein (hsCRP)) with
some MEDAS items was analyzed using t-Tests and a multivariate regression.
Results: The participants of the LIBRE pilot study were 68 in total (33 Intervention, 35 Control). Only participants who
completed both questionnaires were included in this analysis (baseline: 66, month three: 54). The concordance between
these two questionnaires varied between the items (Intraclass correlation coefficient of 0.91 for pulses at the highest and
−0.33 for sugar-sweetened drinks). Mean MEDAS scores (sum of all items) were 9% higher than their FFQ counter-parts at
baseline and 15% after 3 months. Higher fish consumption (at least 3 portions) was associated with lower omega-6 fatty
acid levels (p = 0.026) and higher omega-3 fatty acid levels (p = 0.037), both results being statistically significant.
Conclusions: We conclude that the German MEDAS in its current version could be a useful tool in clinical trials and in
practice to assess adherence to MD.
Trial registration: ClinicalTrials.gov, registered on March 12, 2014, identifier: NCT02087592. World Health Organization
Trial Registration, registered on 3 August 2015, identifier: NCT02087592.
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Background
The MD has been tested for its health benefits in different
at-risk populations with favourable results. For instance,
randomized controlled intervention studies revealed that
MD is effective in the primary prevention of cardiovascu-
lar diseases [1, 2], in lowering hypertension and athero-
genic lipoproteins [3, 4] and in improving diabetes [5].
More recently, studies in the older population showed an
association between MD and improved cognitive function
[6]. Epidemiological studies from the European Prospect-
ive Investigation into Cancer and Nutrition (EPIC) cohort
suggested further that MD might protect against cancer,
especially gastric cancer [7], colorectal cancer [8] and
bladder cancer [9].
Such trials raised the need for a useful tool to assess
MD adherence in study populations. The PREDIMED
consortium established a 14-point MEDAS questionnaire,
which was validated by administering the established FFQ
[10] and MEDAS to 7146 participants from the PRE-
DIMED study. The authors found that the average
MEDAS score estimate was 105% of the FFQ PREDIMED
score estimate, and thus is a valid instrument for rapid es-
timation of adherence to the MD [11]. Moreover, the PRE-
DIMED investigators could show that MEDAS is able to
capture a strong monotonic inverse association between
adherence to MD and obesity indices in a population of
adults with a high cardiovascular risk [12].
In Germany, a multicentre trial, the ‘Lifestyle interven-
tion in BRCA 1/2-mutation carriers’ (LIBRE) was launched
to investigate the effect of a defined lifestyle intervention
on breast cancer incidence in women at high genetic risk
for this type of cancer [13]. Up to 60% of women with
BRCA mutations develop breast or ovarian cancer [14],
but not all of them, suggesting that environmental co-
factors play a role. Indeed, some studies suggested that
physical activity and dietetic intervention help prevent
cancer, including breast cancer [15, 16]. To test the
hypothesis of whether these controllable environmental
factors further modulate cancer risk, the LIBRE trial con-
ducts an intervention with clearly defined sport and nutri-
tion components. The nutritional component of the
intervention was based on the MD. The German transla-
tion of MEDAS was used as an instrument to assess adher-
ence. The purpose of the present study was to validate the
German version of MEDAS.
Methods
Study population
The LIBRE study is divided into two parts: firstly, a feasi-
bility study to prove the practicability of the lifestyle inter-
vention and consequently, the presently recruiting main
trial with the aim of attaining 600 study participants to
demonstrate the effects of the lifestyle intervention on the
breast cancer incidence in women with BRCA1 or BRCA2
genetic mutations. 68 women, who were all participants of
the LIBRE feasibility study, formed the study population
for these analyses. The details of the trial have been pub-
lished elsewhere [13]. The study population (adult women
between 18 and 75 years) was recruited from February
2014 to July 2014 in selected consultation centres of the
German Consortium of Hereditary Breast and Ovarian
Cancer in Kiel, Cologne and Munich. All participants
signed an informed written consent. The trial was ap-
proved by the responsible ethical committees.
Study participants were randomized into two groups
with a ratio of 1:1, stratified by participating centre and
previous breast cancer. The intervention group (IG)
(n = 35) received a detailed lifestyle intervention over
12 months, and the control group (CG) (n = 33) re-
ceived no intervention, but standard recommendations
for a healthier lifestyle. The lifestyle IG received a super-
vised physical exercise training program and nutritional
education based on the MD. In the first 3 months, the
nutritional education took place every fortnight, there-
after at monthly intervals. The CG received minimal nu-
tritional education based on the recommendations of
the German Society of Nutrition (DGE - https://
www.dge.de/en/) “Usual Care in Germany“and some
general advice for increasing activity in everyday life at
the beginning of the study (one session). All participants
were asked to fill out both a full-length FFQ and
MEDAS at study start (baseline) and 3 months later. We
chose both time points to prove whether MEDAS is spe-
cific enough by measuring MD-typical changes during
the intervention. Only data collected within this period
were used for the purposes of the current study. Solely
participants who had completed both questionnaires
were included in the analysis. These were in total 66 par-
ticipants at baseline (34 in the IG and 32 in the CG) and
54 at month three (27 in the IG and 27 in the CG).
We used the guidelines from the International Society
for Pharmacoeconomics and Outcomes Research (ISPOR)
to guide our translation process [17]. MEDAS from the
English PREDIMED-publication [11] was translated into
German and reviewed by two native speakers in German.
It was then translated back into English by a native
speaker. Following this, the final version was read and ap-
proved in a small group of the study team.
Dietary assessment
MEDAS is a 14-item screener, which consists of 12
questions on food consumption frequency and 2 ques-
tions on food intake habits characteristic of the MD
(Table 1). Each question was scored with a 0 or 1. One
point was given for using olive oil as the principal source
of fat for cooking and one for preferring white meat over
red meat, and one for consuming each of the following:
Hebestreit et al. BMC Cancer  (2017) 17:341 Page 2 of 10
 4 or more tablespoons (1 tablespoon = 13.5 g) of
olive oil/d (including that used in frying, salads,
meals eaten away from home, etc.);
 2 or more servings of vegetables/d;
 3 or more pieces of fruit/d;
 fewer than 1 serving of red meat or sausages/d;
 fewer than 1 serving of animal fat/d;
 fewer than 1 cup (1 cup =100 mL) of sugar-
sweetened beverages/d;
 7 or more servings of red wine/wk.;
 3 or more servings of pulses/wk.;
 3 or more servings of fish/wk.;
 fewer than 3 commercial pastries/wk.;
 3 or more servings of nuts/wk.; or
 2 or more servings/wk. of a dish with a traditional
sauce of tomatoes, garlic, onion, or leeks sautéed in
olive oil.
If the condition was not met, 0 points were recorded for
the category. The MEDAS score (sum of above items)
ranged from 0 to 14 points [11].
All participants were also asked to complete a 148-
item semi-quantitative FFQ. The German version had
been validated by the German EPIC investigators [18–21].
For each item it questions the average serving size, de-
scribed by photos, and the food frequency during the
previous 12 months. Furthermore, it contains questions
on cooking oil, frequency of the use of gravy, the fat
content of dairy products, the use of sugar and milk in
coffee and tea, and the seasonal consumption of fruit
and vegetables. The documentation of the question-
naire was done via the study-management-system for
Epidemiology and Public Health, which was developed
and supervised by the Department of Epidemiology of
the German Institute of Human Nutrition Potsdam-
Rehbruecke.
Food intake data recorded by FFQ was grouped into
the food-based dietary components of MEDAS (Table 1).
We validated the dietary assessment data retrieved from
MEDAS by comparing it with the data gathered from
the validated FFQ and confirmed this by associating with
the results from the blood tests.
Table 1 MEDAS questions and transfer of food intake data from FFQ into its food groups
MEDAS question data recorded by FFQ
1. Do you use olive oil as the principal source of fat for cooking? 1 point given: use of olive oil for the preparation of at least 2 of the
following groceries: salad, vegetable, meat/fish (FFQ Question: Pages
14 and 19)
2. How much olive oil do you consume per day (including that used
in frying, salads, meals eaten away from home, etc.)?
1 point given: based on FFQ calculation, if >48 g vegetable oil
3. How many servings of vegetables do you consume per day? 1 point given: based on FFQ calculation, if ≥2 portions of vegetables per
day (including salad, olives, mushrooms)
4. How many pieces of fruit (including fresh-squeezed juice) do you
consume per day?
1 point given: based on FFQ calculation, if ≥3 portions of fruit (including
mixed fruit, mixed stewed fruit and fruit juices)
5. How many servings of red meat, hamburger, or sausages do you
consume per day?
1 point given: based on FFQ calculation, if <100 g meat (beef, veal, pork,
lamb) and processed meat products
6. How many servings (12 g) of butter, margarine, or cream do you
consume per day?
1 point given: based on FFQ calculation, if <1 portion butter, margarine
and cream
7. How many carbonated and/or sugar-sweetened beverages do you
consume per day?
1 point given: based on FFQ calculation, sugar-sweetened beverages <1
portion per day (including lemonade and colas)
8. Do you drink wine? How much do you consume per week? 1 point given: based on FFQ calculation, if ≥7 portions wine (red
and white)
9. How many servings of pulses do you consume per week? 1 point given: ≥ 3 portions pulses per week (page 14)
10. How many servings of fish/seafood do you consume per week? 1 point given: based on FFQ calculation, if ≥3 portions fish, fish products
and seafood per week
11. How many times do you consume commercial (not homemade)
pastry such as cookies or cake per week?
1 point given: based on FFQ calculation, if <3 portions cakes, chocolate,
cookies, sweets with and without chocolate per week
12. How many times do you consume nuts per week? 1 point given: based on FFQ calculation, if ≥3 portions nuts and seeds
per week (page 11)
13. Do you prefer to eat chicken, turkey or rabbit instead of beef, pork,
hamburgers, or sausages?
1 point given: based on FFQ calculation, if g white meat (poultry,
chicken, rabbit) > g red meat (beef, veal, pork, lamb, processed
meat products)
14. How many times per week do you consume boiled vegetables, pasta,
rice, or other dishes with a sauce of tomato, garlic, onion, or leeks
sautéed in olive oil?
1 point given: > 1–2 times a week tomato sauce (page 21)
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Measurement of dietary intake biomarkers in the blood
To confirm whether MEDAS’ tendency towards the MD
is consistent, we selected specific biomarkers in the blood
which are described in the literature to be associated with
consumption of certain MD food components [1, 22, 23].
Blood samples were taken at the same time points as
the completion of both questionnaires (baseline and
after 3 month). Following 30 to 60 min of incubation the
serum was centrifuged at 3000*g for 10 min in the
consultation centres and was overnight delivered chilled
together with the EDTA (ethylene diamine tetraacetic
acid) blood samples to the central laboratory at the Uni-
versity of Hohenheim.
A part of the serum was passed directly to an external la-
boratory (Medizinisches Labor Bremen, Bremen, Germany)
to measure β-carotene by high performance liquid chroma-
tography (HPLC). The rest of the serum aliquots were
stored at −80 °C in Hohenheim until the measurement of
hsCRP using a sandwich Enzyme Immuno Assay (K 9710S,
Immundiagnostik AG, Bensheim, Germany) was done. The
erythrocyte membrane was isolated from the EDTA blood
and also stored at −80 °C in Hohenheim until the fatty acid
profile (omega-6-, omega-3- and omega-9-fatty acids) was
analyzed after acid esterification using gas chromatography/
mass spectrometry by the Institute of Food Chemistry of
the University of Hohenheim [24, 25].
Statistical analysis
Patient characteristics were analyzed descriptively, split by
study arm. For age and Body Mass Index (BMI), a t-Test
was used to determine whether the two groups were sta-
tistically different. For all other characteristics, coded as
binary items, a Chi2 test was used.
We then determined the concordance between the an-
swers to the MEDAS questionnaire compared to the
answers for corresponding questions in the FFQ ques-
tionnaire both at Baseline and at 3 months. First, the
absolute agreement in percentage was calculated, which
was further investigated using Cohen’s kappa (κ) and the
intraclass correlation coefficient (ICC). The relative
agreement between the corresponding items was exam-
ined using the Pearson product–moment correlation.
The agreement between the sum from the MEDAS
questionnaire and the equivalent FFQ questions was ex-
amined using a Bland-Altman analysis. The mean of the
two values was plotted on the x-axis and the difference
on the y-axis, in order to determine possible bias. The
95% limits of agreement lines, defined as the mean dif-
ference ± 1.96 times the standard deviation of the differ-
ences, were also plotted. A linear regression was then
carried out with the difference as the dependent value,
whose line was added to the plot with its corresponding
formula and p-value.
In a further step, we validated whether the MEDAS
questionnaire can specifically determine adherence to a
MD, the association of blood values for β-carotene, the
fatty acids omega-3, omega-6 and omega-9 and hsCRP,
and MEDAS items (β-carotene associated with the
MEDAS item regarding vegetables and fruits; hsCRP,
omega-3 fatty acids, omega-6 fatty acids and omega-9 fatty
acids associated with the MEDAS item regarding olive oil;
omega-3 fatty acids and omega-6 fatty acids associated
with the MEDAS item regarding red meat, fish and nuts).
We first applied a t-Test for independent groups (control
or intervention) for each of the food items and each of the
dietary biomarker values, carried out separately for each
of the two time points. Following this, we carried out a
multivariate linear regression on the associations de-
scribed above, where we also adjusted for the study arm.
The statistical analysis was done using R (program for
statistical computing) in the R Studio environment Version
0.99.902.
Results
Patient characteristics
Patient characteristics at baseline are outlined in Table 2.
The IG comprised 35 women at this point in time, while
the CG comprised 32. Considering attributes such as
BMI, age and history of breast cancer, these groups did
not differ statistically significantly from one another. Both
groups included a number of smokers (11% in the IG and
9% in the CG). A vegetarian diet was also followed by a
group of the study participants (6% in the IG and
13% in the CG).
Item by item agreement
The absolute and relative agreements between the FFQ
and the MEDAS questionnaires were calculated at base-
line and at 3 months for the whole sample (Table 3).
This concordance at Baseline was highest for questions
1: olive oil as principal source of fat (Pearson’s product–
moment correlation 0.70, κ 0.70 and an ICC of 0.68),
and 12: nuts (Pearson’s product–moment correlation
0.72, κ 0.70 and an ICC of 0.68). After 3 months the
highest concordance was obtained for questions 9:
pulses (Pearson’s product–moment correlation 0.86, κ
Table 2 Study patient characteristics at baseline (n = 67)
Intervention group (MD)
n = 34
Control group
N = 32
Age [years]a 42 (27–72) 42 (24–68)
BMI [kg per m2]a 23 (18–45) 23 (18–43)
History of breast cancerb 24 (71%) 21 (66%)
Smokerb 4 (11%) 3 (9%)
Vegetarianb 2 (6%) 4 (13%)
amedian (range)
bnumbers (percent)
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0.85 and an ICC of 0.91), and 12: nuts (Pearson’s prod-
uct–moment correlation 0.78, κ 0.77 and an ICC of
0.76). Questions 7: sugar-sweetened beverages at Base-
line and 2: daily olive oil had the lowest concordances
with negative values.
MEDAS total score agreement
The MEDAS score was analyzed using a Bland-Altman
plot (Fig. 1). The mean MEDAS scores were 15% higher
than the FFQ score at baseline and 23% higher after
3 months, with the median MEDAS score being higher
Table 3 Agreement between MEDAS and FFQ (German)
Question Baseline (n = 66) 3 months (n = 54)
r AA κ ICC r AA κ ICC
1 0.70 0.87 0.70 (0.51 to 0.89) 0.68 (0.07 to 1.3) 0.51 0.87 0.51 (0.22 to 0.81) 0.55 (−0.19 to 1.28)
2 0.29 0.86 0.23 (−0.07 to 0.53) 0.21 (−0.35 to 0.76) −0.09 0.70 −0.034 (−0.1 to 0.03) −0.03 (−0.08 to 0.02)
3 0.30 0.63 0.28 (0.06 to 0.49) 0.14 (−0.26 to 0.54) 0.25 0.62 0.19(−0.02 to 0.4) 0.15 (−0.36 to 0.66)
4 0.42 0.70 0.36 (0.15 to 0.56) 0.28 (−0.33 to 0.88) 0.08 0.25 0.087 (−0.16 to 0.31) −0.03 (−0.06 to 0.01)
5 0.58 0.81 0.50 (0.28 to 0.72) 0.52 (−0.20 to 1.24) 0.40 0.87 0.39 (0.03 to 0.75) 0.04 (−0.35 to 1.14)
6 0.45 0.73 0.45 (0.22 to 0.67) 0.32 (−0.33 to 0.97) 0.23 0.61 0.22 (−0.03 to 0.48) 0.06 (−0.20 to 0.33)
7 −0.04 0.91 −0.03 (−0.07 to 0.02) −0.11 (−0.14 to −0.08) n/a 0.96 n/a −0.33 (−0.38 to −0.28)
8 0.35 0.83 0.28 (−0.001 to 0.57) 0.51 (−0.28 to 1.30) 0.24 0.91 0.21 (−0.19 to 0.6) 0.37 (−0.57 to 1.31)
9 n/a 0.92 n/a n/a 0.86 0.96 0.85 (0.66 to 1.1) 0.91 (0.68 to 1.14)
10 0.25 0.84 0.21 (−0.18 to 0.61) 0.22 (−0.42 to 0.87) 0.28 0.74 0.21 (−0.04 to 0.45) 0.13 (−0.28 to 0.55)
11 0.44 0.77 0.37 (0.14 to 0.6) 0.33 (−0.33 to 0.99) 0.64 0.83 0.61 (0.39 to 0.83) 0.58 (−0.13 to 1.28)
12 0.72 0.86 0.70 (0.52 to 0.87) 0.68 (0.05 to 1.30) 0.78 0.89 0.77 (0.61 to 0.94) 0.76 (0.23 to 1.28)
13 0.18 0.43 0.06 (−0.01 to 0.13) 0.03 (−0.14 to 0.20) 0.13 0.27 0.03 (−0.01 to 0.08) 0.01 (−0.15 to 0.13)
14 0.39 0.69 0.38 (0.16 to 0.6) 0.25 (−0.33 to 0.83) 0.17 0.60 0.17 (−0.01 to 0.43) 0.02 (−0.14 to 0.18)
AA = absolute agreement, r = Pearson’s product–moment correlation, κ = Cohen’s Kappa with the confidence intervals in brackets, ICC = Intraclass Correlation
Coefficient with the confidence intervals in brackets
Fig. 1 Bland-Altman plots showing the differences between the MEDAS score aggregated from MEDAS and FFQ questionnaires at baseline and
after 3 months. The red dashed and dotted lines indicate the mean bias and its 95% confidence interval. The blue dashed and dotted lines depict
limits of agreement and their 95% confidence intervals
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than the FFQ equivalent by 1 point at baseline and 2
points after 3 months. This corresponds to a mean
difference of 1.27 at baseline and 2.12 after 3 months,
which defines the bias towards higher score sums being
obtained by the MEDAS questionnaire. Linear regression
analysis revealed a significant increase of the bias with
increasing score values (p < 0.001 for baseline, p < 0.001
after 3 months).
Measurement of dietary intake biomarkers in the blood
The possible association between laboratory measure-
ments and intake of particular food groups was first ana-
lyzed on a per item basis (Table 4). After the 3-month MD
intervention some of these associations showed a statis-
tical significance or near-significance. Consumption of at
least 3 portions of fish per week was associated with lower
omega-6 fatty acid levels (p = 0.035) and higher omega-3
fatty acid levels (p = 0.053). Consumption of at least 3 por-
tions of fruit per day was associated with higher levels of
β-carotene (p = 0.056). Consumption of at least 2 portions
of vegetables per day was associated with higher levels of
β-carotene (p = 0.004). We have depicted these associa-
tions in Fig. 2.
We also examined the same associations in a multi-
variate model, as reported in Table 5. Consumption of at
least three portions of fish per week showed increased
levels of omega-3 (p = 0.037) and decreased levels of
omega-6 fatty acid (p = 0.026) in the blood, both of
which were statistically significant.
Discussion
MEDAS was developed for the Spanish PREDIMED
study to expediently determine adherence to the MD
and allow an immediate feedback to the patient. This
short screener is a validated tool for the rapid assess-
ment of adherence to the MD [11], which is why it was
decided to use a German-translation of this question-
naire in the LIBRE study. However, the original MEDAS
was not in German. To validate the German translation
of this questionnaire, we used the validated German full-
length FFQ as reference.
In general agreement between FFQ and MEDAS ques-
tionnaires was of a fair or better level (0.4 and larger
values for agreement coefficients) for about half of the
MEDAS questions [22]. These differences are likely due
to the way FFQ is structured and to the fact that it is dif-
ferently analyzed. FFQ measures the food frequency of a
selected list of German foods with standardized portion
sizes for the previous 12 months. These answers are
then used to calculate intake for food groups while
MEDAS directly asks for the habits and consumption
frequency of specific amounts of specific Mediterranean
Table 4 MEDAS food groups association with dietary biomarkers in the blood
Baseline (n = 66) At 3 months(n = 54)
MEDAS food group association
with dietary biomarker(s)
Mean for group
with 0 point (n)
Mean for group
with 1 point (n)
p-value Mean for group
with 0 point (n)
Mean for group
with 1 point (n)
p-value*
vegetables with
β-carotene [μg/l] 859.7 (26) 889.3 (39) 0.868 487.8 (9) 918.91 (45) 0.004
fruit with
β-carotene [μg/l] 786.6 (36) 1009.51 (29) 0.183 689.5 (25) 984.181 (29) 0.056
how much olive oil with
hsCRP [mg/l] 0.6 (54) 0.51 (11) 0.337 0.7 (39) 0.51 (15) 0.218
omega 3 [%] 14.0 (54) 13.7 (11) 0.763 13.2 (39) 13.81 (15) 0.513
omega 6 [%] 27.5 (54) 27.3 (11) 0. 831 25.0 (39) 25.01 (15) 0.983
omega 9 [%] 14.08 (54) 13.77 (11) 0.185 15.4 (39) 15.16 (15) 0.362
red meat with
omega 3 [%] 14.2 (21) 13.8 (44) 0.665 12.1 (8) 13.3 (45) 0.202
omega 6 [%] 27.5 (21) 27.4 (44) 0.908 25.0 (8) 25.2 (45) 0.849
fish with
omega 3 [%] 14.1 (59) 12.6 (6) 0.280 12.6 (38) 15.11 (16) 0.053
omega 6 [%] 27.4 (59) 27.9 (6) 0.629 25.6 (38) 23.41 (16) 0.035
nuts with
omega 3 [%] 13.5 (38) 14.5 (27) 0.230 13.8 (23) 13.2 (30) 0.559
omega 6 [%] 27.8 (38) 26.9 (27) 0.811 24.4 (23) 25.4 (30) 0.361
*based on the t-test
Only significant P values are bold
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foods during the previous week. In short, the FFQ mea-
sures specific details whereas the MEDAS is measuring
for components of an overall dietary pattern. For the
conversion of food intake data from FFQ into MEDAS
food groups only aggregated FFQ data can be used in
most cases. For instance, question 3 on vegetables and
question 4 on fruits each comprised several questions
from FFQ. A further example is that FFQ provides, 3no
information on how many times boiled vegetables, pasta,
rice, or other dishes with a sauce of tomato, garlic,
onion, or leeks sautéed in olive oil are consumed. It asks
only about the consumption of tomato sauce, but no fur-
ther details (e.g. way of cooking or ingredients). Only
question 9 (pulses) which has a high concordance is
based on a direct answer of FFQ. Additionally, in this
study FFQ was completed again within after an interval
of just 3 months, which means that the answers for the
two time points for FFQ in our analysis overlap for a
period of time.
The Bland-Altman analysis showed that the MEDAS
score yields higher values for the sum of all items than
FFQ with respect to MD. This confirms the results of
Schröder et al., who report that the average MEDAS
Mediterranean diet score estimate was 105% of the FFQ
PREDIMED score estimate [11]. The larger difference be-
tween the two score sets after 3 months can be a result of
the MD-based intervention in the IG. The MEDAS
Fig. 2 Association of vegetable consumption (question 3 of the MEDAS questionnaire) and fruit consumption (question 4 of the MEDAS questionnaire)
with β-carotene; and association of fish consumption (question 10 of the MEDAS questionnaire) with omega-6 fatty acids and omega-3 fatty acids after
3 months (V1) [0 = 0 point in the MEDAS question; 1 = 1 point in the MEDAS question]. The p-value was calculated using the t-test
Table 5 Dietary blood biomarkers association with MEDAS food
groups, assessed using multivariate regression
Baseline At 3 months
Dietary biomarker association
with MEDAS food group
Estimate p-Value Estimate p-Value*
β-Carotene with
Fresh vegetables −22 0.197 446 0.104
Fruits 237 0. 287 366 0.147
omega 3 with
Amount of olive oil −0.99 0.415 1.1 0.230
Red meat −0.99 0.282 2.2 0.099
Fish −2.1 0.133 2.1 0.037
Nuts 1.5 0.094 −1.2 0.225
omega 6 with
Amount of olive oil 0.269 0.775 −0.4 0.702
Red meat 0.243 0.734 −1.3 0.360
Fish 0.834 0.433 −2.4 0.026
Nuts −0.96 0.162 1.5 0.147
omega 9 with
Amount of olive oil −0.095 0.114 −0.054 0.542
HsCRP with
Amount of olive oil −0.234 0.402 −0.3 0.161
*adjusted for the study arm
Only significant P values are bold
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questionnaire was specifically developed to detect the ad-
herence of an individual’s diet to the principles of the MD.
Therefore, MEDAS is more sensitive for MD items than
FFQ, resulting in higher scores in individuals abiding by
the MD. The FFQ questions, however, assesses the general
food intake and does not focus particularly on the con-
sumption of Mediterranean food. Two points can be con-
sidered relevant for detecting an adequate implementation
of MD in life.
To confirm if the MEDAS’ tendency towards the MD is
consistent, we analyzed the association between certain
MD food items and selected dietary intake biomarkers in
the blood thought to be associated with these food items.
The traditional MD is characterized by a high intake of
olive oil, fruit, nuts, vegetables, and cereals; a moderate in-
take of fish and poultry; and a low intake of dairy prod-
ucts, red meat, processed meats, and sweets; while wine is
consumed moderately and only together with meals
[1, 23]. In the literature, it is described that a high
consumption of fruits and vegetables is associated with
higher β-carotene blood levels [26]. Kitamura et al. have
previously positively correlated frequency of vegetables
and fruit intake with β-carotene, among other things [26].
In our study, subjects who consumed at least two portions
of vegetables per day according to the MEDAS question-
naire had higher β-carotene blood levels than those who
consumed fewer than two portions at both time points.
Those who consumed at least three portions of fruit per
day according to the MEDAS questionnaire also had
higher β-carotene levels in their blood than those who
consumed fewer than three portions. This data supports
that the MEDAS results reflect the reported intake of par-
ticular nutrients charachterisic of a MD pattern.
The MD is rich in poly- and mono-unsaturated fatty
acids due to the high consumption of olive oil, fish and
nuts [27]. The amount of saturated fatty acids in the
MD is lower than in the Western-style diet, because red
meat and processed meat products play a minor part in
the Mediterranean nutrition. The Western-style diet is
characterized by its highly processed and refined foods
and high contents of sugars, salt and fat and protein
from red meat [28]. Olive oil is characterized by a high
content of mono-unsaturated fatty acids. Oleic acid
(C18:1, n-9) is the main component of olive oil [27].
Therefore, we hypothesized that a high consumption of
olive oil, fish and nuts and low red meat intake are asso-
ciated with changes in the fatty acid profile measured in
erythrocyte membrane. Barcelo et al. described elevated
values of omega-3-fatty acids and low values of omega-
6-fatty acids following high olive oil consumption, while
the omega-9-fatty acid amount remained unchanged
[29]. Our data demonstrated that, more than four table-
spoons of olive oil per day were associated with a ten-
dency to higher serum levels of all unsaturated fatty
acids (omega-6, −3 and −9) compared with the values
measured in subjects who consumed less olive oil. Tak-
kumen et al. described an association between high fish
consumption and a change in the omega-6 and −3-fatty
acids profile. The amount of omega-6-fatty acids de-
creased while that of omega-3-fatty acids increased [30].
At least three portions of fish and seafood per week were
statistically significantly associated with lower omega-6-
fatty acids values (24% compared to 26.3%, p = 0.016)
and higher omega-3-fatty acids values. While high meat
consumption is associated with higher omega-6-fatty
acids values [30], such tendencies could also be seen in
this study.
Barceló et al. [29] also reported an association between
hsCRP values and olive oil consumption. According to
their data, a MD enriched with olive oil (1 litre per week)
resulted in a reduction of the plasma hsCRP concentra-
tion. Such tendencies could also be seen in this study. In-
dividuals who consume more than four tablespoons of
olive oil per day had lower values of hsCRP than individ-
uals who consume less olive oil. The described associa-
tions between certain food items and blood values
indicate that the MEDAS score indeed reflects a MD.
Within this context, MEDAS provides reasonable esti-
mates to adequately rank MD adherence.
Study limitations comprise firstly, a small sample size
meaning the statistical tests would only have small
power. A further limitation of this study is that our find-
ings may not apply to the general population as the par-
ticipants belonged to a selected population who may
have a particular dietary behaviour due to their know-
ledge about their genetic disposition for breast cancer.
We will be using the German MEDAS in our main
trial that aims to recruit 600 study participants. We de-
cided to use the adherence to MD measured by the
MEDAS score as one of 3 co-primary endpoints [31].
Conclusions
Despite the study limitations, we conclude that the present
version of MEDAS could be a reasonable tool in determin-
ing adherence to a MD in German-speaking populations.
This short screener is a valid tool for the rapid assessment
of adherence to the MD that may also be useful not only
for trials but also in clinical practice. The MEDAS score
would allow an immediate feedback to study participants
or patients regarding their adherence to MD.
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